Dr Nabhani-Gebara is an Associate Professor in Oncology Pharmacy at Kingston University London. She has a doctorate in pharmacy with post graduate qualifications and specialisation in oncology She has a global view of cancer care as she has trained and worked on three different continents.
She sits on the British Oncology Pharmacy Association (BOPA) executive board, and is the founding chair of the BOPA EDI (equality, diversity and inclusion) subcommittee and the chair of its research committee.
Research focus: evolving cancer services to optimise early detection and follow up care, technology enabled care (including artificial intelligence), and optimising the quality of cancer care through equity and inclusion.
Her research has attracted significant funding from national and international organisations such as InnovateUK and HORIZON2020 (currently: INCISIVE project).
Updated: September 2023